Adverse events related to blood transfusion

Indian Journal of Anaesthesia

Volumn 58, Issue 5, 2014, Pages 543-551

  Sahu, Sandeep ^a   Hemlata, ^a   Verma, Anupam ^a  

^a SANJAY GANDHI POSTGRADUATE INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Adverse events; Anaesthesia; Blood transfusion; Complications; Non infectious

Indexed keywords

ACUTE HYPOTENSIVE TRANSFUSION REACTION; AIR EMBOLISM; ALLOIMMUNIZATION; ANAPHYLAXIS; BLOOD CLOTTING DISORDER; BLOOD TRANSFUSION; BLOOD TRANSFUSION REACTION; FEBRILE NONHAEMOLYTIC TRANSFUSION REACTION; HEMOLYSIS; HUMAN; HYPERKALEMIA; HYPOKALEMIA; HYPOTHERMIA; IMMUNOMODULATION; IRON OVERLOAD; METABOLIC AND HAEMOSTATIC DERANGEMENT; PURPURA; REVIEW; SCREENING; TRANSFUSION ASSOCIATED CIRCULATORY OVERLOAD; TRANSFUSION ASSOCIATED DYSPNOEA; TRANSFUSION ASSOCIATED GRAFT VERSUS HOST DISEASE; TRANSFUSION RELATED ACUTE LUNG INJURY; TRANSFUSION RELATED SEPSIS; URTICARIA;

EID: 84925010423     PISSN: 00195049     EISSN: None     Source Type: Journal    
DOI: 10.4103/0019-5049.144650     Document Type: Review

References (41)

1. Popovsky MA, Robillard P, Schipperus M, Stainsby D, Tissot JD, Wiersum J. ISBT Working Party on Haemovigilance. Proposed standard definitions for surveillance of noninfectious adverse transfusion reactions. 2011. Available from: http://www.ihn-org.com/wp-content/uploads/2011/06/ ISBT-definitions-for-non-infectious-transfusion-reactions. pdf. [Last accessed on 2014 Jun 15].
2. Hendrickson JE, Hillyer CD. Noninfectious serious hazards of transfusion. Anesth Analg 2009;108:759-69.
3. th Ed. Bethesda, MD: American Association of Blood Banks; 2008:715-749.
4. WHO. Manual of Clinical Use of Blood in Surgery and Anaesthesia. Available from: http://www.who.int/bloodsafety/ clinical-use/en/manual-EN.pdf. [Last accessed on 2014 Jun 25].
5. Heddle NM, Klama L, Meyer R, Walker I, Boshkov L, Roberts R, et al. A randomized controlled trial comparing plasma removal with white cell reduction to prevent reactions to platelets. Transfusion 1999;39:231-8.
6. Hennino A, Bérard F, Guillot I, Saad N, Rozières A, Nicolas JF. Pathophysiology of urticaria. Clin Rev Allergy Immunol 2006;30:3-11.
7. Domen RE, Hoeltge GA. Allergic transfusion reactions: An evaluation of 273 consecutive reactions. Arch Pathol Lab Med 2003;127:316-20.
8. Tang AW. A practical guide to anaphylaxis. Am Fam Physician 2003;68:1325-32.
9. Shimada E, Tadokoro K, Watanabe Y, Ikeda K, Niihara H, Maeda I, et al. Anaphylactic transfusion reactions in haptoglobin-deficient patients with IgE and IgG haptoglobin antibodies. Transfusion 2002;42:766-73.
10. Ellis AK, Day JH. Diagnosis and management of anaphylaxis. Can Med Assoc J 2003;169:307-11.
11. Bux J, Sachs UJ. The pathogenesis of transfusion-related acute lung injury (TRALI). Br J Haematol 2007;136:788-99.
12. Looney MR, Gilliss BM, Matthay MA. Pathophysiology of transfusion-related acute lung injury. Curr Opin Hematol 2010;17:418-23.
13. Goldberg AD, Kor DJ. State of the art management of transfusion-related acute lung injury (TRALI). Curr Pharm Des 2012;18:3273-84.
14. Müller MC, van Stein D, Binnekade JM, van Rhenen DJ, Vlaar AP. Low-risk transfusion-related acute lung injury donor strategies and the impact on the onset of transfusion-related acute lung injury: A meta-analysis. Transfusion 2014.
15. Vlaar AP. Transfusion-related acute lung injury: Current understanding and preventive strategies. Transfus Clin Biol 2012;19:117-24.
16. Roth VR, Kuehnert MJ, Haley NR, Gregory KR, Schreiber GB, Arduino MJ, et al. Evaluation of a reporting system for bacterial contamination of blood components in the United States. Transfusion 2001;41:1486-92.
17. Kopko PM, Holland PV. Mechanisms of severe transfusion reactions. Transfus Clin Biol 2001;8:278-81.
18. Wagner SJ, Robinette D, Friedman LI, Miripol J. Diversion of initial blood flow to prevent whole-blood contamination by skin surface bacteria: An in vitro model. Transfusion 2000;40:335-8.
19. Bolton-Maggs PH, Cohen H. Serious Hazards of Transfusion (SHOT) haemovigilance and progress is improving transfusion safety. Br J Haematol 2013;163:303-14.
20. rd ed. Philadelphia: Lippincott Williams and Wilkins; 2002. p. 831-51.
21. Blumberg N, Heal JM, Gettings KF, Phipps RP, Masel D, Refaai MA, et al. An association between decreased cardiopulmonary complications (transfusion-related acute lung injury and transfusion-associated circulatory overload) and implementation of universal leukoreduction of blood transfusions. Transfusion 2010;50:2738-44.
22. Kalra A, Palaniswamy C, Patel R, Kalra A, Selvaraj DR. Acute hypotensive transfusion reaction with concomitant use of angiotensin-converting enzyme inhibitors: A case report and review of the literature. Am J Ther 2012;19:e90-4.
23. Arnold DM, Molinaro G, Warkentin TE, DiTomasso J, Webert KE, Davis I, et al. Hypotensive transfusion reactions can occur with blood products that are leukoreduced before storage. Transfusion 2004;44:1361-6.
24. Dzik WH, Kirkley SA. Citrate toxicity during massive blood transfusion. Transfus Med Rev 1988;2:76-94.
25. th ed. Oxford, UK: Blackwell Science, Ltd.; 1997. p. 241-77.
26. Mirski MA, Lele AV, Fitzsimmons L, Toung TJ. Diagnosis and treatment of vascular air embolism. Anesthesiology 2007;106:164-77.
27. Pineda AA, Vamvakas EC, Gorden LD, Winters JL, Moore SB. Trends in the incidence of delayed hemolytic and delayed serologic transfusion reactions. Transfusion 1999;39:1097-103.
28. Tahhan HR, Holbrook CT, Braddy LR, Brewer LD, Christie JD. Antigen-matched donor blood in the transfusion management of patients with sickle cell disease. Transfusion 1994;34:562-9.
29. Petz LD, Calhoun L, Shulman IA, Johnson C, Herron RM. The sickle cell hemolytic transfusion reaction syndrome. Transfusion 1997;37:382-92.
30. Bauer MP, Wiersum-Osselton J, Schipperus M, Vandenbroucke JP, Briët E. Clinical predictors of alloimmunization after red blood cell transfusion. Transfusion 2007;47:2066-71.
31. Brand A. Alloimmune platelet refractoriness: Incidence declines, unsolved problems persist. Transfusion 2001;41:724-6.
32. Santoso S, Kiefel V. Human platelet alloantigens. Wien Klin Wochenschr 2001;113:806-13.
33. rd ed. Philadelphia: Lippincott Williams and Williams; 2002. p. 867-77.
34. Moore FA, Moore EE, Sauaia A. Blood transfusion. An independent risk factor for postinjury multiple organ failure. Arch Surg 1997;132:620-4.
35. Ghio M, Contini P, Mazzei C, Merlo A, Filaci G, Setti M, et al. In vitro immunosuppressive activity of soluble HLA class I and Fas ligand molecules: Do they play a role in autologous blood transfusion? Transfusion 2001;41:988-96.
36. Schroeder ML. Transfusion-associated graft-versus-host disease. Br J Haematol 2002;117:275-87.
37. Triulzi D, Duquesnoy R, Nichols L, Clark K, Jukic D, Zeevi A, et al. Fatal transfusion-associated graft-versus-host disease in an immunocompetent recipient of a volunteer unit of red cells. Transfusion 2006;46:885-8.
38. Przepiorka D, LeParc GF, Stovall MA, Werch J, Lichtiger B. Use of irradiated blood components: Practice parameter. Am J Clin Pathol 1996;106:6-11.
39. rd ed. Bethesda, MD: AABB Press; 2007. p. 275-99.
40. Ziman A, Klapper E, Pepkowitz S, Smith R, Garratty G, Goldfinger D. A second case of post-transfusion purpura caused by HPA-5a antibodies: Successful treatment with intravenous immunoglobulin. Vox Sang 2002;83:165-6.
41. Lindsted G, Larsen R, Krøigaard M, Garvey LH, Poulsen LK, Mosbech H, et al. Transfusion-associated anaphylaxis during anaesthesia and surgery - A retrospective study. Vox Sang 2014;107:158-65.